Skip to main content
Loading

Market Outlook: Is the IPO Window Opening Wider and What to Watch?

October 16, 2024
Venetian Room
While the rate of IPOs this year is slightly increased versus 2023, the market is still much less active since 2021 and hoping the Q3 interest rate cut of 0.5% sparks additional investor support. This session will examine how private company CEOs should be preparing now for the types of IPOs that will be best received by the public markets, along with the implications for any opportunistic secondary offerings, amid an era of heightened geopolitical and market volatility.
Moderator
Jakob Dupont, Executive Partner - Sofinnova Investments
Speakers
Emily Park - MD, Principal - DCVC Bio
Carolyn Ng - PhD, Partner and Managing Director - TPG Life Sciences Innovations
Elaine Cheung, Chief Business Officer - Moonwalk Biosciences
Peter Garcia, Chief Financial Officer - ALX Oncology
Colin Walsh - PhD, Managing Director, Growth Equity - Goldman Sachs

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS